Steven S Lebow

M.D. | Neurology


  2828 Chicago Ave South, Suite 200, Minneapolis
     Minnesota, 55407-1320
  612-879-1000    612-879-9111 Maps & Directions
Steven S Lebow is a Minneapolis, Minnesota based neurologist who is specialized in Neurology. His current practice location is 2828 Chicago Ave South, Suite 200, Minneapolis. Patients can reach him at 612-879-1000 or can fax him at 612-879-9111. Steven S Lebow is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1245234665.
Steven S Lebow specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Steven S Lebow speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Steven S Lebow
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:2828 Chicago Ave South, Suite 200, Minneapolis,
Minnesota, 55407-1320
Phone:612-879-1000
Fax:612-879-9111
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1245234665
NPI Enumeration Date: 13 Jun, 2005
NPI Last Update On: 21 Oct, 2008

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Steven S Lebow
2828 Chicago Ave South, Suite 200
Minneapolis, Minnesota
Zip: 55407-1320
Phone Number: 612-879-1000
Fax Number: 612-879-9111
Patients can reach Steven S Lebow at 2828 Chicago Ave South, Suite 200, Minneapolis, Minnesota or can call to book an appointment on 612-879-1000.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.